在肺高血压中的β2激动剂.

Resumption of injecting drug use following release from prison in Australia.

Drug and alcohol dependence·2016

Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia.

Drug and alcohol dependence·2015

Malignant mesothelioma.

British medical bulletin·2010

Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer.

Thorax·2008

Expression and prognostic significance of hypoxia-inducible factor 1alpha (HIF-1alpha) in malignant pleural mesothelioma (MPM).

Lung cancer (Amsterdam, Netherlands)·2005

Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2005

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Mutation-Induced Pocket Deactivation: How Ser353/Pro245 Alters KCa2.2 vs. KCa3.1 Ligand Selectivity.

Archiv der Pharmazie·2026

A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease.

Science translational medicine·2026

Efficacy of DPP-4 Inhibitors on Seated and Ambulatory Blood Pressure in Type 2 Diabetes Mellitus.

Diabetes, obesity & metabolism·2026

Ameliorative Effects of Spirulina platensis Protein Hydrolysate on Oxidative Stress and Dyslipidemia in Model Animal.

Foods (Basel, Switzerland)·2026

Comparison of essential drug lists: concordance, differences, and the need for core lists in times of crisis.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment.

JAMA network open·2026

相关实验视频

在肺高血压中的β2激动剂.

相关概念视频

Resumption of injecting drug use following release from prison in Australia.

Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia.

Malignant mesothelioma.

Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer.

Expression and prognostic significance of hypoxia-inducible factor 1alpha (HIF-1alpha) in malignant pleural mesothelioma (MPM).

Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Mutation-Induced Pocket Deactivation: How Ser353/Pro245 Alters K<sub>Ca</sub>2.2 vs. K<sub>Ca</sub>3.1 Ligand Selectivity.

A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease.

Efficacy of DPP-4 Inhibitors on Seated and Ambulatory Blood Pressure in Type 2 Diabetes Mellitus.

Ameliorative Effects of <i>Spirulina platensis</i> Protein Hydrolysate on Oxidative Stress and Dyslipidemia in Model Animal.

Comparison of essential drug lists: concordance, differences, and the need for core lists in times of crisis.

Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment.

相关实验视频

在肺高血压中的β2激动剂.

相关概念视频

相关文章